Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CME GROUP INC. Director's Dealing 2014

Sep 16, 2014

29871_dirs_2014-09-16_148ccf89-befe-4ff9-98de-b90d9f25df63.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2014-09-14

Reporting Person: Piell Hilda Harris (Sr MD & Chief HR Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-09-14 Common Stock Class A F 207.0 $79.33 Disposed 18646 Direct
2014-09-15 Common Stock Class A F 440.0 $79.82 Disposed 18206 Direct
2014-09-15 Common Stock Class A A 4384.0 $0.0 Acquired 22590 Direct
2014-09-15 Common Stock Class A M 1145.0 $54.37 Acquired 23735 Direct
2014-09-15 Common Stock Class A S 1145.0 $79.0 Disposed 22590 Direct
2014-09-15 Common Stock Class A M 2085.0 $54.3 Acquired 24675 Direct
2014-09-15 Common Stock Class A S 2085.0 $79.0 Disposed 22590 Direct
2014-09-15 Common Stock Class A S 2267.0 $80.0 Disposed 20323 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-09-15 Non-Qualified Stock Option (right to buy) $54.3 M 2085.0 Disposed 2020-09-15 Common Stock Class A (2085) Direct
2014-09-15 Non-Qualified Stock Option (right to buy) $54.37 M 1145.0 Disposed 2021-09-15 Common Stock Class A (1145) Direct

Footnotes

F1: Ms. Piell surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/14/2014.

F2: Ms. Piell surrendered shares to the Company in order to fulfill tax withholding obligations upon the vesting of restricted stock on 9/15/2014.

F3: This sale was completed pursuant to the terms of a pre-arranged trading plan established in accordance with Rule 10b5-1.

F4: These options were granted on September 15, 2012. They vest over a four-year period, with 25% vesting one year after the grant date and 25% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances.

F5: These options were granted on September 15, 2011. They vest over a four-year period, with 25% vesting one year after the grant date and 25% vesting on that same date in each of the following three years, subject to acceleration or termination in certain circumstances.